Opis działalności
Boundless Bio is the company dedicated to treating oncogene amplified cancers and is the leader in the field of ecDNA, driving the discovery and development of a novel therapeutic approach to targeting oncogene amplified cancers.
Zarząd & Rada nadzorcza
| CEO |
| Zachary Hornby |
| Zarząd |
| Jami Rubin, Neil Abdollahian, Amy Berkley, Chris Hassig, David Hinkle, Shailaja Kasibhatla, Peter Krein, Jessica Oien, Anthony “Tony” Pinkerton, Klaus Wagner, Meredith Wesley, Sara Weymer |
| Rada nadzorcza |
| Jonathan Lim, Christine Brennan, Kristina Burow, James “Jamie” Christensen,, Zachary Hornby, Jennifer Lew, Nancy Whiting |
Dane firmy
| Nazwa: |
Boundless Bio Inc. |
| Adres: |
9880 Campus Point Dr, Suite 120,San Diego, CA 92121 |
| Telefon: |
858-766-9912 |
| Fax: |
- |
| E-mail: |
partnerships@boundlessbio.com
|
| Internet: |
https://boundlessbio.com/ |
| Przemysł: |
Biotechnologia |
| Sektor: |
Biotechnologia |
| Podsektor: |
Biotechnologia |
| Koniec roku finansowego: |
31.12 |
| Free float: |
- |
| Data IPO: |
28.03.2024 |
